Premarket Safety and Efficacy Studies for ADHD Medications in Children

Open Access

Peer-reviewed

Research Article

Florence T. Bourgeois ,

* E-mail: florence.bourgeois@childrens.harvard.edu

Affiliations Division of Emergency Medicine, Boston Children’s Hospital, Boston, Massachusetts, United States of America, Department of Pediatrics, Harvard Medical School, Boston, Boston, Massachusetts, United States of America, Children’s Hospital Informatics Program at the Harvard-MIT Division of Health Sciences and Technology, Boston Children’s Hospital, Boston, Massachusetts, United States of America
⨯
Jeong Min Kim,

Affiliation Faculty of Arts and Sciences, Wellesley College, Wellesley, Massachusetts, United States of America
⨯
Kenneth D. Mandl

Affiliations Division of Emergency Medicine, Boston Children’s Hospital, Boston, Massachusetts, United States of America, Department of Pediatrics, Harvard Medical School, Boston, Boston, Massachusetts, United States of America, Children’s Hospital Informatics Program at the Harvard-MIT Division of Health Sciences and Technology, Boston Children’s Hospital, Boston, Massachusetts, United States of America, Harvard Medical School Center for Biomedical Informatics, Boston, Massachusetts, United States of America
⨯

Reader Comments (0)

ADHD
Is the Subject Area "ADHD" applicable to this article?

Thanks for your feedback.
Safety studies
Is the Subject Area "Safety studies" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Clinical trials
Is the Subject Area "Clinical trials" applicable to this article?

Thanks for your feedback.
Pediatrics
Is the Subject Area "Pediatrics" applicable to this article?

Thanks for your feedback.
Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.
Drugs
Is the Subject Area "Drugs" applicable to this article?

Thanks for your feedback.
Post-marketing trials
Is the Subject Area "Post-marketing trials" applicable to this article?

Thanks for your feedback.